3.93 USD
↗ 0.05 (1.29%)PRE MARKET (AS OF 07:06 AM EDT)
TLRY is currently priced at $3.93. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, TLRY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 24, 2026.
Open?$3.91
High?$3.96
Low?$3.90
Prev. Close?$3.88
Volume?17.8K
Avg. Volume?3.6M
VWAP?$3.92
Rel. Volume?0.00x
Bid / Ask
Bid?$3.33 × 100
Ask?$4.46 × 100
Spread?$1.13
Midpoint?$3.90
Valuation & Ratios
Market Cap?479.0M
Shares Out?119.6M
Float?1.1B
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?0.31
EPS?-$10.88
Dividend?0.32%
Ex-Dividend?N/A
News
Profile
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Employees
2.8K
Market Cap
479.0M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Website
Listed
2015-01-23
Address
655 MADISON AVENUE
NEW YORK, NY 10065
Phone: 519.322.8800
NEW YORK, NY 10065
Phone: 519.322.8800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?35
Short Sent.?83
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.51Distress
Confidence?51%Low
Short InterestModerate
Short % of Float?1.46%Low
Short Interest?16.2M
Days to Cover?4.2
Free Float1.1B
Avg Daily Volume3.9M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.62Strong
Quick Ratio?1.48Adequate
Cash Ratio?0.79Adequate
Debt/Equity?0.16Low
ValuationATTRACTIVELY VALUEDvs 2 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.31CHEAP▾
Peers100
S&P97
P/S?0.56CHEAP▾
Peers100
S&P95
P/FCF?N/A▾
EV/EBITDA?19.3FAIR▾
Peers100
S&P28
EV/Sales?0.61CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-86.2%WEAK▾
S&P3
ROA?-64.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-50958000
Enterprise Value?$523.9M
Fundamentals ratios updated end of day